c myc (Proteintech)
Proteintech is a verified supplier 
98
Structured Review
Proteintech
c myc
C Myc, supplied by Proteintech, used in various techniques. Bioz Stars score: 98/100, based on 10874 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+c+myc/GAPDH+Monoclonal+antibody/10__1038_slash_s41419___026___09303___x-78-27-28
Average 98 stars, based on 10874 article reviews
C Myc, supplied by Proteintech, used in various techniques. Bioz Stars score: 98/100, based on 10874 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+c+myc/GAPDH+Monoclonal+antibody/10__1038_slash_s41419___026___09303___x-78-27-28
Average 98 stars, based on 10874 article reviews
c myc - by Bioz Stars,
2026-11
98/100 stars
Images
Related Articles
Control:Article Title: KCTD1 stabilizes c-Myc to upregulate PD-L1 and suppress anti-tumor immunity in hepatocellular carcinoma Article Snippet: .. Primary antibodies included anti-KCTD1 (bs-16924R, Bioss, Beijing, China; 1:200), anti-PD-L1 (66248-1, Proteintech, Chicago, USA; 1:500), Article Title: KCTD1 stabilizes c-Myc to upregulate PD-L1 and suppress anti-tumor immunity in hepatocellular carcinoma. Article Snippet: .. Primary antibodies included anti-KCTD1 (bs-16924R, Bioss, Beijing, China; 1:200), anti-PD-L1 (66248-1, Proteintech, Chicago, USA; 1:500), Western Blot:Article Title: BRD4 is a key regulator of STING expression Article Snippet: Compounds: JQ1 (HY-13030), dBET6 (HY-112588), CQ (Chloroquine; HY-17589 A), MG132 (HY-13259), AZD5153 (HY-100653), decitabine (HY-A0004), CMA (Cridanimod; HY-W011890), DMXAA (Vadimezan; HY-10964), diABZI (HY-112921 A), MSA-2 (HY-136927), I-BET151 (HY-13235), I-BET726 (HY-13960), olaparib (HY-10162), and talazoparib (BMN673; HY-16106) were purchased from MCE (New Jersey, USA). .. The primary antibodies and concentrations were as follows: anti-STING (abcam, ab252560, 1:1000 dilution for WB; ab288157, 1:200 dilution for IF), anti-GAPDH (abcam, ab8245, 1:1000 dilution), Article Title: cGAS-STING Pathway-Induced BST2 Enhances HPV-Infected Keratinocyte Proliferation in Condyloma Acuminata. Article Snippet: .. Antibodies for Western blot analysis included: anti-GAPDH (Abbkine, Wuhan, China), anti-β-Tubulin (Abbkine, Wuhan, China), anti-BST2 (Cell Signaling Technology, Danvers, MA, USA), anti-STING (Cell Signaling Technology, Danvers, MA, USA), anti-STING (phospho S366) (Cell Signaling Technology, Danvers, MA, USA), anti-IRF-3 (Cell Signaling Technology, Danvers, MA, USA), anti-IRF-3 (phosphor S386) (Cell Signaling Technology, Danvers, MA, USA), anti-MEK1 + MEK2 (Abcam, Cambridge, UK), anti-MEK1 + MEK2 (phospho S218 + S222) (Abcam, Cambridge, UK), anti-ERK1 + ERK2 (Abcam, Cambridge, UK), anti-ERK1 (phospho T202) + ERK2 (phospho T185) (Abcam, Cambridge, UK), and Article Title: miRNA-378a-5p attenuates the development of abdominal aortic aneurysm via ABLIM1-MKL1 signaling pathways Article Snippet: Briefly, protein concentrations were determined using a BCA protein assay kit (Thermo Fisher Scientific, Inc.). .. The membranes followed by immunoblotting with the primary antibodies: anti-α-SMA (1:1,000; cat. no. Ab7817; Abcam), anti-SM22-α (1:1,000; cat. no. Ab14016; Abcam), anti-CNN1 (1:1,000; cat. no. Ab46794; Abcam), anti-MMP2 (1:1,000; cat. no. Ab92536; Abcam), anti-ABLIM1 (1:1,000; cat. no. PA5-70451; Thermo Fisher Scientific, Inc.), anti-MKL1 (1:1,000; cat. no. Ab219981 ; Abcam), anti-Flag (1:1,000; cat. no. sc-166355; Santa Cruz Biotechnology, Inc.), anti-His (1:1,000; cat. no. 66005-1-Ig; Proteintech Group, Inc.), Cell-Signaling:Article Title: Targeting Cys328 in the STAT3 DNA-binding domain with the germacrane-type sesquiterpene lactone SCP-7 inhibits colorectal Cancer growth in vitro and in vivo. Article Snippet: Signal transducer and activator of transcription 3 (STAT3) is a critical oncogenic driver hyperactivated in approximately 70% of human cancers, especially colorectal cancer (CRC), making it an attractive therapeutic target.. Currently, the discovery of STAT3 inhibitors is primarily focused on the SH2 domain, however, there are still problems such as insufficient inhibitory activity and poor clinical efficacy.. Targeting the DNA-binding domain (DBD) is a direct and effective strategy for inhibiting STAT3 function; but due to the lack of suitable targeting sites and design methods, reported compounds and their mechanisms of action are limited. |